State registration was "OnkoIFA-CA 15-3" by GC "Alcor Bio". This is a diagnostic kit 10 domestic producers. Novelty is most suitable for monitoring therapy in patients with breast cancer. All previous models are also used to identify tumor antigens - proteins produced by cells of different tumors. They can detect more than 10 types of cancer.
Set "OnkoIFA-CA15-3" is used to quantitatively determine the concentration of cancer antigen CA 15-3 serum and human plasma by enzyme immunoassay.
Its advantage is to study a large number of sera without dilution. This minimizes the risk of errors when using the set and reduces the time spent on cancer diagnosis . In addition, part of the "OnkoIFA-CA 15-3" Control Serum allows to verify the results of the analysis.
Some tumor markers have high specificity, that is produced only by cells specific malignancy, while others can be defined for different types of tumors. Proper analysis of the antigens can detect high risk of developing cancer; point to the alleged source of the tumor patients before the start of an in-depth examination; diagnose cancer recurrence; evaluate the radical surgical treatment (ie, removed all of the tumor or not), and monitor the effectiveness of the treatment in general.
Industry News
Go back to the main page
No comments:
Post a Comment